Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-26-000030
Filing Date
2026-08-06
Accepted
2026-08-06 16:24:26
Documents
54
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20260630.htm   iXBRL 10-Q 801653
2 EX-31.1 vtvt-20260630xexx311.htm EX-31.1 10044
3 EX-31.2 vtvt-20260630xexx312.htm EX-31.2 10021
4 EX-32.1 vtvt-20260630xexx321.htm EX-32.1 4922
5 EX-32.2 vtvt-20260630xexx322.htm EX-32.2 4887
11 GRAPHIC vtvt-20260630_g1.jpg GRAPHIC 1557693
  Complete submission text file 0001641489-26-000030.txt   7913470

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20260630.xsd EX-101.SCH 37158
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20260630_cal.xml EX-101.CAL 33285
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20260630_def.xml EX-101.DEF 230299
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20260630_lab.xml EX-101.LAB 483135
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20260630_pre.xml EX-101.PRE 331110
58 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20260630_htm.xml XML 460933
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 261249525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)